Skip to content

Evaluation of the Tyto Thermometer When Used in Clinical Care Setting

Evaluation of the Tyto Thermometer When Used in Clinical Care Setting

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03452020
Enrollment
124
Registered
2018-03-02
Start date
2018-01-24
Completion date
2018-06-24
Last updated
2018-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Temperature Measurement

Brief summary

Patients who present to the Emergency Department will be evaluated for eligibility to the study. Those meeting all the inclusion criteria and none of the exclusion criteria will undergo an informed consent process and will sign a written consent. Within each age group both afebrile and febrile patients will be represented. The patients will be divided into 3 study groups by age: Group 1: up to 1 year Group 2: 1 to 5 years Group 3: older than 5 years The following temperature measurements will be taken: 1. Three temperature measurements using the Tyto thermometer 2. Temperature measurement using the standard of care 3. Three temperature measurements using the predicate device

Interventions

DEVICETemperature measurementsusing the Tyto thermometer, the standard of care thermometer and the predicate thermometer

Temperature measurements using the Tyto thermometer, the standard of care thermometer and the predicate thermometer

Sponsors

Tyto Care Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. Male or female, of any age 2. Subject or Parent/Guardian: able to communicate with study personnel; 3. Subject or Parent/Guardian: able to understand the nature of the study and provide written informed consent 4. Subject or Parent/Guardian willing to comply with study procedures

Exclusion criteria

1. Cognitive impairment, history of dementia, psychiatric disorders, mental disorders or PDD. 2. Subject or legal guardian unwilling to sign informed consent form 3. Those with signs or recent history of inflammation or infection of the forehead or at the Reference Clinical Test site (site of temperature measurement in any one of the devices used). 4. Subjects currently using cooling blankets, ice on their forehead or fans. 5. Subjects receiving treatment with antipyretics, barbiturates, antipsychotics for the past 3 hours. 6. Subjects receiving current systemic treatment with thyroid preparations, corticosteroids or underwent immunizations during the past 7 days. 7. Subjects with documented illicit drug use or alcoholic intoxication 8. Those participating in a clinical trial of an investigational medicinal product 9. Carriers of multi drug resistant bacteria 10. Pregnancy 11. CTAS score of 1-2

Design outcomes

Primary

MeasureTime frame
Body temperature measurementa period of no more than 12 minutes

Countries

Israel

Contacts

Primary ContactStella Raizelman Perry, MSc
stellar@tytocare.com972.72.221.0750
Backup ContactOfer Tzadik, Eng
ofert@tytocare.com972524761210

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026